abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

ITGB4
Back
Total number of drugs
6
Phase II and later clinical stages
0%
Involving companies
8
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
AAA-604AAA-604Therapeutic radiopharmaceuticalsNeoplasms Digestive System Disorders Endocrinology and Metabolic Diseaseintegrin subunit beta 3 inhibitors integrin subunit beta 4 inhibitorsNovartis AGNovartis AGPhase 1AAA-604
detail  >
CS-5006CS-5006Antibody drug conjugate (ADC) ADCNeoplasmsintegrin subunit beta 4 inhibitors DNA topoisomerase I inhibitorsCornerstone Pharmaceutical Co., LtdCornerstone Pharmaceutical Co., LtdPreclinicalPreclinicalβ-glucuronide Beta-葡萄糖醛酸苷Exatecan 依喜替康CS-5006
detail  >
GENA-120GENA-120Antibody drug conjugate (ADC) ADCNeoplasmsintegrin subunit beta 4 inhibitors DNA topoisomerase I inhibitorsGenome & Co.Genome & Co.PreclinicalGENA-120
detail  >
GENB-120GENB-120Antibody drug conjugate (ADC) ADCNeoplasmsintegrin subunit beta 4 inhibitors Tumor-associated calcium signal transducer 2 inhibitorsGenome & Co.Genome & Co.PreclinicalGENB-120
detail  >
Halofuginone HydrobromideHalofuginone HydrobromideDegradable Molecular GlueImmune System Diseases Infectious Diseases Skin and Musculoskeletal DiseasesCollagen inhibitors Aminoacyl-tRNA synthetase inhibitors integrin subunit beta 4 inhibitors Angiogenesis inhibitorsAkashi Therapeutics IncNational Institute of Malaria ResearchICGEB New DelhiHunan University of Chinese MedicineAcademy of Scientific & Innovative ResearchPreclinicalPreclinicalUnited StatesHalofuginone Hydrobromide
detail  >
WO2024208354WO2024208354Antibody Fragment-Drug Conjugates (FDCs)NeoplasmsCornerstone Pharmaceutical Co., LtdCornerstone Pharmaceutical Co., LtdDiscoveryWO2024208354
detail  >
Total 6 data
1